English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Recently Jonsson et al . reported on increased cortical bone mineralization as a side effect in imatinib treated adult patients with chronic myelogenous leukemia (CML).[1][1] Also for pediatric CML targeted therapy by this tyrosine kinase inhibitor has been replacing stem cell transplantation (SCT)

Longitudinal growth retardation in a prepuberal girl with chronic myeloid leukemia on long-term treatment with imatinib